Micro- and macrovascular complications, and subjects on insulin treatment were also more frequent in the CHD group than in the non-CHD group (P < 0.05 and P < 0.001, respectively; Additional file 1: Table S1). The gene discussed is INS; the disease is coronary artery disorder.